Skip to content

Homoeopathy, Lifestyle Changes, and Counselling in Individuals with Binge Eating and Obesity

Efficacy of Add-on Homoeopathy, with Lifestyle Modifications and Cognitive Behaviour Therapy in Binge Eating Disorder- Comorbid Obesity: A Randomized, Single-Blind Comparative Pilot Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089737
Enrollment
230
Registered
2025-06-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories

Interventions

Intervention1: Indicated Homoeopathic medicinesalong with Lifestyle Modification (LSM) and cognitive behavioural therapy (CBT): Indicated Homoeopathic medicines in centesimal potency will be prescrib

Sponsors

Central Council for Research in Homoeopathy, New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants with ages between 18-60 years, of all Gender 2. Overweight and Obese participants (BMI greater than 25) as per WHO classification of BMI. 3. Participants meeting DSM-5 criteria for Binge Eating Disorder.

Exclusion criteria

Exclusion criteria: 1. Participants with BMI greater than equal to 40 (class III) according to WHO classification 2. Participants already undergoing treatment ( allopathic, ayurveda, homoeopathic) for weight reduction. 3. Participants currently using contraceptive pills; medications with effect on lipid metabolism i.e. thiazide and loop diuretics, beta and alpha receptor blockers; anti-epileptic drugs, anti-psychotics medications regularly over the last 1 month or more. 4. Pregnant and lactating women. 5. Participants suffering from systemic and other endocrine disorders e.g. Uncontrolled hypertension greater than 180/110mmHg (Grade 3) and Malignant Hypertension,Diabetes Mellitus, Diabetes Insipidus, Cushing Syndrome, Addisons Disease. 6. Participants suffering from other eating disorders such as anorexia nervosa, and bulimia nervosa, 7. Participants already diagnosed with severe psychiatric disorder such as Major Depressive Disorders, Scizophrenia, Bipolar Disorders, Organic Psychosis

Design outcomes

Primary

MeasureTime frame
1. To assess the reduction in the severity of binge eating episodes with DSM-5 Criteria.Timepoint: Assessed at baseline and at 02 months, 04 months, and 06 months

Secondary

MeasureTime frame
1. To assess the changes in Waist circumference and Waist-hip ratio. 2.To assess the changes in the Global Physical Activity Questionnaire (GPAQ)/10-point weight-related sign and symptom measure (WRSSM). 3.To assess the changes in Fasting Blood Sugar and HbA1c 4. To assess the changes in lipid profile 5. To assess the changes in Health-Related Quality of Life (HRQOL)Timepoint: 1. Changes in Waist circumference and Waist-hip ratio, Global Physical Activity Questionnaire (GPAQ)/10-point weight-related sign and symptom measure (WRSSM), Fasting Blood Sugar,changes in Health-Related Quality of Life (HRQOL) to be assessed at baseline and at 02 months, 04 months, and 06 months 2. Changes in Hba1c, lipid profile to be assessed at baseline and 6 months

Countries

India

Contacts

Public ContactDr Renu Mittal

Central Council for Research in Homoeopathy

drdivyataneja@gmail.com9810305068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026